| Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621) |
|---|
| 04/06/2005 | CN1195783C Polymerization of olefins |
| 04/06/2005 | CN1195738C 2'-substd. 1, 1'-biphenyl-2-carbonamides, method for production thereof, use thereof as medicament and pharmaceutical preparation contg. said compounds |
| 04/05/2005 | US6875760 Glucagon antagonists/inverse agonists |
| 04/05/2005 | US6875736 Methods for identifying RNA binding compounds |
| 04/05/2005 | CA1341478C Therapeutic methods using catalytic antibodies |
| 03/31/2005 | WO2005028427A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | US20050070715 Methods for synthesis of acyloxyalkyl compounds |
| 03/31/2005 | CA2539165A1 Cinnamoyl compound and use of the same |
| 03/31/2005 | CA2539159A1 Aminoalkylamide substituted cyclohexyl derivatives |
| 03/31/2005 | CA2538960A1 Cinnamoyl compound and use of the same |
| 03/30/2005 | EP1517881A1 4-(3,3-dihalo-allyloxy)phenoxy alkyl derivatives |
| 03/30/2005 | EP1010690B1 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use |
| 03/30/2005 | CN1602291A Novel bensophenone derivatives or salts thereof |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/30/2005 | CN1194960C Method for preparing 4,5-diamino shikimic acid derivative |
| 03/29/2005 | US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents |
| 03/29/2005 | US6872847 Process for the preparation of alkyl-n-(3-dimethylamino) alkylcarbamates |
| 03/24/2005 | WO2005026372A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 03/24/2005 | WO2004060882A8 Cb 1/cb 2 receptor ligands and their use in the treatment of pain |
| 03/24/2005 | US20050065353 Mitosis agents; antitumor agents; anticancer agents |
| 03/24/2005 | US20050065350 Method for forming a carbon-carbon or carbon-heteroatom linkage |
| 03/24/2005 | US20050065339 Amino-alkyl derivatives |
| 03/24/2005 | US20050065210 Anticholesterol agents; antilipemic agents; arteriosclerosis; cardiovascular disorders; parasiticides; antitumor agents; antiproliferative agents; antidiabetic agents |
| 03/24/2005 | US20050065191 Central nervous system disorders; therapy for diseases of glutamate receptor signal transmission |
| 03/24/2005 | US20050065147 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 03/24/2005 | CA2551022A1 Polyethyleneglycol-modified lipid compounds and uses thereof |
| 03/24/2005 | CA2537794A1 Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and carbamoyloxy compounds as therapeutic agents |
| 03/23/2005 | EP1516870A1 Process for producing aromatic compound derivative by reaction of aromatic compound substituted with sulfamoyloxy, sulfinamoyloxy, or carbamoyloxy group, with nucleophilic agent |
| 03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
| 03/23/2005 | EP1045832B1 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof |
| 03/23/2005 | CN1597665A New technology of synthesizing fenoxycarb |
| 03/23/2005 | CN1597103A Catalyst for synthesizing cyclohexyl amino methyl formate |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/22/2005 | US6870065 Such as N-hydroxysuccinimidyl-5-(N,N-bis-(2-(4-(N-((3-hydroxy-4-(methoxy-carbonyl) phenyl)methyl)carbamoyl) butanoylamino)ethyl)carbamoyl)butanoate for biochemical conjugation |
| 03/22/2005 | US6870058 Polyhydroxy, dienyl lactones and intermediates |
| 03/22/2005 | US6869957 Non-peptide tachykinin receptor antagonists |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | US20050059800 Process and intermediates for the preparation of (1R,2S,5S)-3-azabicyclo[3,1,0]hexane-2-carboxamide, N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[(2S)-2-[[[1,1-dimethylethyl]amino]carbonylamino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl |
| 03/17/2005 | US20050059735 Cyclic amino acid derivatives useful as pharmaceutical agents |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester |
| 03/17/2005 | US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants |
| 03/17/2005 | US20050059648 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
| 03/17/2005 | US20050059608 Pharmaceutical compounds |
| 03/17/2005 | CA2538175A1 Method for the manufacture of l-threonine-o-(1,1-dimethylethyl)-1,1-dimethylethyl ester |
| 03/16/2005 | EP1115758B1 Polymerization of olefins |
| 03/16/2005 | CN1193010C Heterocyclonitrogen heteroethane derivant with antiviral activity |
| 03/15/2005 | US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency |
| 03/15/2005 | US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus |
| 03/15/2005 | US6867192 Inhibiting eosinophil infiltration into lungs; such as 2-((-2-((2-(2-Benzoylphenoxy)acetyl)amino)-4-methylpentanoyl)-amino)-3-(4 -(((4-((2-phenylacetyl)amino)-1-piperidinyl)-carbonyl)oxy)phenyl)propanoic acid |
| 03/15/2005 | CA2221946C Production process of cyclic compound |
| 03/10/2005 | WO2005021499A1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity |
| 03/10/2005 | WO2005020882A2 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | CA2824106A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/10/2005 | CA2537093A1 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 03/09/2005 | EP1511473A2 Bis-aromatic alkanols |
| 03/09/2005 | EP1018008B1 Method of identification of leads or active compounds |
| 03/09/2005 | CN1592623A Acetylene derivatives having human matabotropic glutamate receptor antagonistic activity |
| 03/09/2005 | CN1590386A Sidechain-bearing taxanes and method for the preparation thereof |
| 03/09/2005 | CN1192015C Cell adhesion inhibitors |
| 03/08/2005 | US6864390 Antiepileptic agents; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864386 Fluorinated compounds |
| 03/08/2005 | US6864290 Statine derivatives for the treatment of Alzheimer's disease |
| 03/08/2005 | US6864285 Hypotensive agents; antihistamines; immunology moderators; antiinflammatory agents |
| 03/03/2005 | WO2005019174A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/03/2005 | WO2005019163A2 Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
| 03/03/2005 | WO2005000803A3 Asymmetric urea compound and process for producing asymmetric compound by asymmetric conjugate addition reaction with the same as catalyst |
| 03/03/2005 | US20050049383 Crosslinking plural polymers through mechanical bonding with a rotaxane structure consisting of a shaft and rings; recycling by decrosslinking the crosslinked body having a disulfide bond in the presence of thiols |
| 03/03/2005 | US20050049310 Aryl and heteroaryl compounds, compositions and methods of use |
| 03/03/2005 | US20050049249 Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
| 03/03/2005 | CA2535350A1 Acetylene derivatives as inhibitors of histone deacetylase |
| 03/02/2005 | EP1509254A1 New agents for magnetic imaging method |
| 03/02/2005 | EP1278741B1 Muscarinic agonists |
| 03/01/2005 | US6861547 Chemical intermediate, corresponding hydrochloride salt of tautomer of functional group -C(=NH2.Cl)-NH-C(=O)-O-R2 |
| 02/24/2005 | WO2005016871A1 Process for the synthesis of iodopropynyl butylcarbamate in an aqueous solution of a suitable surfactant |
| 02/24/2005 | WO2005016869A1 Novel dendrimer compound, a biochip using the same and a fabricating method thereof |
| 02/24/2005 | WO2005016866A2 Process for producing optically actiive beta-amino acid derivatives |
| 02/24/2005 | WO2005016865A1 Gamma hydroxy carbamate compounds and methods of making and using the same |
| 02/24/2005 | WO2005016277A2 Arylsulfonamidobenzylic compounds |
| 02/24/2005 | WO2005016240A2 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/24/2005 | US20050043371 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists |
| 02/24/2005 | US20050043308 Process for total synthesis of ecteinascidins and intermediates therefor |
| 02/24/2005 | CA2534298A1 Aryl carbamate oligomers for hydrolyzable prodrugs and prodrugs comprising same |
| 02/24/2005 | CA2533638A1 Arylsulfonamidobenzylic compounds |
| 02/23/2005 | EP1508565A1 Process for the preparation of optically active aminoalcohols |
| 02/23/2005 | EP1507760A1 Cyanoguanidine prodrugs |
| 02/23/2005 | EP1317421B1 2-amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/23/2005 | EP0876337B1 New lh-rh antagonists with improved effectiveness |
| 02/23/2005 | CN1585633A Phenethanolamine derivatives for treatment of respiratory diseases |
| 02/23/2005 | CN1190421C Method for producing cyclic compounds |
| 02/23/2005 | CN1190419C Compound with electron providing and receiving functional groups |
| 02/22/2005 | US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 02/22/2005 | CA2129039C Tri-substituted phenyl derivatives as phosphodiesterase inhibitors |
| 02/17/2005 | WO2005014534A1 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014533A2 Aryl and heteroaryl compounds, compositions, and methods of use |
| 02/17/2005 | WO2005014532A1 Aryl and heteroaryl compounds, compositions and methods of use |
| 02/17/2005 | WO2003099192A8 Bis-aromatic alkanols |